Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | ADH7 | P40394 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL318192 | 0.92 | TP53 (0.41) | TP53OPRM1CA1NR1I2SMPD1 | |
| SCHEMBL8764616 | 0.90 | TP53 (0.39) | TP53CA1NR1I2SMPD1CA2 | |
| SCHEMBL27647758 | 0.83 | TP53 (0.37) | TP53OPRM1CA1NR1I2SMPD1 | |
| SCHEMBL28130426 | 0.82 | TP53 (0.42) | TP53CA1FAAHSMPD1CA2 | |
| SCHEMBL7987581 | 0.82 | TP53 (0.42) | TP53CA1FAAHSMPD1CA2 | |
| SCHEMBL1655277 | 0.82 | TP53 (0.42) | TP53CA1FAAHSMPD1CA2 | |
| SCHEMBL7062487 | 0.82 | TP53 (0.42) | TP53CA1FAAHSMPD1CA2 | |
| SCHEMBL13276078 | 0.82 | TP53 (0.42) | TP53CA1FAAHSMPD1CA2 | |
| Ammonia Solution, Strong SCHEMBL5446113 | 0.81 | TP53 (0.36) | TP53OPRM1CA1NR1I2SMPD1 | |
| SCHEMBL28058761 | 0.81 | TP53 (0.40) | TP53OPRM1CA1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2552399-A1 | CARE POLYMERS | The Procter & Gamble Company (US) | 2013-02-06 | — | — | EP | disclosed |
| EP-2552997-A1 | CARE POLYMERS | The Procter & Gamble Company (US) | 2013-02-06 | — | — | EP | disclosed |
| WO-2011123736-A1 | CARE POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-06 | — | — | WO | disclosed |
| WO-2011123734-A1 | CARE POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-06 | — | — | WO | disclosed |
| US-20110243874-A1 | CARE POLYMERS | THE PROCTER & GAMBLE COMPANY | 2011-10-06 | — | — | US | disclosed |
| US-20110243875-A1 | CARE POLYMERS | THE PROCTER & GAMBLE COMPANY | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110243875-A1 | CARE POLYMERS | SMURF1, PUF60, PCBP1 | TP53 1325/4885OPRM1 3453/4885CA1 3923/4885 |
| US-20110243874-A1 | CARE POLYMERS | SMURF1, PUF60, PCBP1 | TP53 1325/4885OPRM1 3453/4885CA1 3923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.